Idt Australia Limited (IDT:ASX)

63.5¢

right-arrow Created with Sketch. -0.025 (-3.79%)
MCAP $158.3M
Last trade 16.10pm 27/09/2021 20mins delayed

Latest Announcements

21/09/2021IDTIdt Australia Limited
15/09/2021IDTIdt Australia Limited
15/09/2021 Price SensitivePSIDTIdt Australia Limited
08/09/2021 Price SensitivePSIDTIdt Australia Limited
27/08/2021IDTIdt Australia Limited
25/08/2021IDTIdt Australia Limited
25/08/2021 Price SensitivePSIDTIdt Australia Limited
25/08/2021IDTIdt Australia Limited

Company Overview

IDT Australia Limited is an Australia-based pharmaceutical manufacturing company. The Company is engaged in the supply of products and provision of research and development and other technical services within the pharmaceutical and allied industries. The Company specializes in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging and pharmacy services. It provides services for new drug development and scale-up, commercial active drug manufacture as well as a various oral and injectable finished drug dose forms. Its sterile manufacturing suite is designed to liquid fill and lyophilise a range of sterile pharmaceutical and biopharmaceutical drug products. Its current goods manufacturing practices (cGMP) facilities manufactures a range of medicinal cannabis products for local and international markets.

IDT in the news

Over FY21, IDT Australia (IDT) has reported a 209.6 per cent increase…
IDT Australia (IDT) shares have jumped today after the company began assessing…
IDT Australia can now manufacture medicinal hemp products to Good Manufacturing Practice…

Search Previous Announcements